Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer - Cutsem, E V; Vervenne, W L; Bennouna, J (Journal of Clinical Oncology, 2009)
et al.